These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34950771)

  • 1. Current management of cancer pain in Italy: Expert opinion paper.
    Marinangeli F; Saetta A; Lugini A
    Open Med (Wars); 2022; 17(1):34-45. PubMed ID: 34950771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
    Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
    PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain.
    Ferrer Albiach C; Villegas Estévez F; López Alarcón MD; de Madariaga M; Carregal A; Arranz J; Trinidad Martín-Arroyo JM; Jiménez López AJ; Sanz Yagüe A
    J Pain Res; 2019; 12():2125-2135. PubMed ID: 31372030
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian recommendations for the management of breakthrough cancer pain.
    Daeninck P; Gagnon B; Gallagher R; Henderson JD; Shir Y; Zimmermann C; Lapointe B
    Curr Oncol; 2016 Apr; 23(2):96-108. PubMed ID: 27122974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy.
    Zucco F; Bonezzi C; Fornasari D
    Adv Ther; 2014 Jul; 31(7):657-82. PubMed ID: 25005168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough cancer pain in 2020.
    Løhre ET; Thronæs M; Klepstad P
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):94-99. PubMed ID: 32332210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
    Alarcón MDL; Estévez FV; Cabezón-Gutiérrez L; Padrós MC; Martín-Arroyo JMT; Rebollo MA; Jiménez-López AJ; Sanz-Yagüe A
    J Geriatr Oncol; 2019 Jul; 10(4):643-652. PubMed ID: 31036463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain.
    Darbà J; Kaskens L; Sánchez-de la Rosa R
    Clinicoecon Outcomes Res; 2013; 6():1-9. PubMed ID: 24368889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough cancer pain: review and calls to action to improve its management.
    Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V
    Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose fentanyl sublingual spray for breakthrough cancer pain.
    Taylor DR
    Clin Pharmacol; 2013; 5():131-41. PubMed ID: 23901300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts.
    Camps Herrero C; Antón Torres A; Cruz-Hernández JJ; Carrato A; Constenla M; Díaz-Rubio E; Feyjoo Saus M; Garcia-Foncillas J; Gascón P; Guillem V
    J Pain Res; 2019; 12():2349-2358. PubMed ID: 31534359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group.
    Mercadante S; Marchetti P; Cuomo A; Mammucari M; Caraceni A;
    Support Care Cancer; 2016 Feb; 24(2):961-968. PubMed ID: 26438145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R; Fullarton JR; Bennett MI
    J Pain Symptom Manage; 2013 Oct; 46(4):573-80. PubMed ID: 23380337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough cancer pain: twenty-five years of study.
    Mercadante S; Portenoy RK
    Pain; 2016 Dec; 157(12):2657-2663. PubMed ID: 27653423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.